Advertisement

PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary

Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD)
      Nearly one-third of all major congenital anomalies are heart defects, with an estimated 9 per 1000 live births afflicted by congenital heart disease (CHD) worldwide.
      • van der Linde D.
      • Konings E.E.
      • Slager M.A.
      • Witsenburg M.
      • Helbing W.A.
      • Takkenberg J.J.
      • Roos-Hesselink J.W.
      Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.
      Remarkable advances in care have resulted in impressive gains in survival such that more than 90% of children with CHD in developed countries today are expected to survive to adulthood.
      • Khairy P.
      • Ionescu-Ittu R.
      • Mackie A.S.
      • Abrahamowicz M.
      • Pilote L.
      • Marelli A.J.
      Changing mortality in congenital heart disease.
      Consequently, the past decades have witnessed historical shifts in population demographics, as adults now outnumber children with CHD. Population-based estimates indicate that there are currently more than 1 million adults with CHD in the United States alone, more than 100,000 in Canada, and 1.8 million in Europe.
      • Marelli A.J.
      • Mackie A.S.
      • Ionescu-Ittu R.
      • Rahme E.
      • Pilote L.
      Congenital heart disease in the general population: changing prevalence and age distribution.
      • Moons P.
      • Engelfriet P.
      • Kaemmerer H.
      • Meijboom F.J.
      • Oechslin E.
      • Mulder B.J.
      Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey.
      • Go A.S.
      • Mozaffarian D.
      • Roger V.L.
      • et al.
      Heart disease and stroke statistics—2013 update: a report from the American Heart Association.
      Rhythm disorders, which span the entire spectrum of bradyarrhythmias and tachyarrhythmias, are among the most prominent complications encountered by adults with CHD.
      • Walsh E.P.
      • Cecchin F.
      Arrhythmias in adult patients with congenital heart disease.
      Arrhythmias range in symptomatology and significance, from inconsequential and benign to poorly tolerated and potentially fatal. Taken together, arrhythmias are a leading cause of morbidity, impaired quality of life, and mortality in adults with CHD.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • van der Linde D.
        • Konings E.E.
        • Slager M.A.
        • Witsenburg M.
        • Helbing W.A.
        • Takkenberg J.J.
        • Roos-Hesselink J.W.
        Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.
        J Am Coll Cardiol. 2011; 58: 2241-2247
        • Khairy P.
        • Ionescu-Ittu R.
        • Mackie A.S.
        • Abrahamowicz M.
        • Pilote L.
        • Marelli A.J.
        Changing mortality in congenital heart disease.
        J Am Coll Cardiol. 2010; 56: 1149-1157
        • Marelli A.J.
        • Mackie A.S.
        • Ionescu-Ittu R.
        • Rahme E.
        • Pilote L.
        Congenital heart disease in the general population: changing prevalence and age distribution.
        Circulation. 2007; 115: 163-172
        • Moons P.
        • Engelfriet P.
        • Kaemmerer H.
        • Meijboom F.J.
        • Oechslin E.
        • Mulder B.J.
        Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey.
        Eur Heart J. 2006; 27: 1324-1330
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • et al.
        Heart disease and stroke statistics—2013 update: a report from the American Heart Association.
        Circulation. 2013; 127: e6-e245
        • Walsh E.P.
        • Cecchin F.
        Arrhythmias in adult patients with congenital heart disease.
        Circulation. 2007; 115: 534-545
        • Khairy P.
        EP challenges in adult congenital heart disease.
        Heart Rhythm. 2008; 5: 1464-1472
        • Warnes C.A.
        • Williams R.G.
        • Bashore T.M.
        • et al.
        ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary.
        J Am Coll Cardiol. 2008; 52: 1890-1947
        • American College of Cardiology Foundation and American Heart Association
        Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines.
        XXXX: XX: American College of Cardiology Foundation and American Heart Association. 2010; : 1-88
        • American College of Cardiology
        Summary of recommendations—care of the adult with congenital heart disease.
        J Am Coll Cardiol. 2001; 37: 1167-1169
        • Silversides C.K.
        • Marelli A.
        • Beauchesne L.
        • et al.
        Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary.
        Can J Cardiol. 2010; 26: 143-150
        • Baumgartner H.
        • Bonhoeffer P.
        • De Groot N.M.
        • et al.
        ESC guidelines for the management of grown-up congenital heart disease (new version 2010).
        Eur Heart J. 2010; 31: 2915-2957
        • Garekar S.
        • Paules M.M.
        • Reddy S.V.
        • Turner D.R.
        • Sanjeev S.
        • Wynne J.
        • Epstein M.L.
        • Karpawich P.P.
        • Ross R.D.
        • Forbes T.J.
        Is it safe to perform cardiac catheterizations on adults with congenital heart disease in a pediatric catheterization laboratory?.
        Catheter Cardiovasc Interv. 2005; 66: 414-419
        • Walsh E.P.
        Interventional electrophysiology in patients with congenital heart disease.
        Circulation. 2007; 115: 3224-3234
        • Sherwin E.D.
        • Triedman J.K.
        • Walsh E.P.
        Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts.
        Circ Arrhythm Electrophysiol. 2013; 6: 1032-1040
        • Heggie J.
        • Karski J.
        The anesthesiologist’s role in adults with congenital heart disease.
        Cardiol Clin. 2006; 24 (vi): 571-585
        • Patel M.S.
        • Kogon B.E.
        Care of the adult congenital heart disease patient in the United States: a summary of the current system.
        Pediatr Cardiol. 2010; 31: 511-514
        • Green M.S.
        • Guerra P.G.
        • Krahn A.D.
        2010 Canadian Cardiovascular Society/Canadian Heart Rhythm Society training standards and maintenance of competency in adult clinical cardiac electrophysiology.
        Can J Cardiol. 2011; 27: 859-861
        • Vetter V.L.
        • Silka M.J.
        • Van Hare G.F.
        • Walsh E.P.
        ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 4: recommendations for training guidelines in pediatric cardiac electrophysiology endorsed by the Heart Rhythm Society.
        J Am Coll Cardiol. 2005; 46: 1391-1395
        • Walsh E.P.
        • Bar-Cohen Y.
        • Batra A.S.
        • Dick II, M.
        • Erickson C.
        • Fish F.
        • Hamilton R.M.
        • Kanter R.J.
        • Reed J.H.
        • Van Hare G.F.
        • Vetter V.L.
        • Webster G.
        Recommendations for advanced fellowship training in clinical pediatric and congenital electrophysiology: a report from the training and credentialing committee of the Pediatric and Congenital Electrophysiology Society.
        Heart Rhythm. 2013; 10: 775-781
        • Naccarelli G.V.
        • Conti J.B.
        • DiMarco J.P.
        • Tracy C.M.
        Task force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management endorsed by the Heart Rhythm Society.
        J Am Coll Cardiol. 2008; 51: 374-380
        • Klewer S.E.
        • Samson R.A.
        • Donnerstein R.L.
        • Lax D.
        • Zamora R.
        • Goldberg S.J.
        Comparison of accuracy of diagnosis of congenital heart disease by history and physical examination versus echocardiography.
        Am J Cardiol. 2002; 89: 1329-1331
        • Khairy P.
        • Marelli A.J.
        Clinical use of electrocardiography in adults with congenital heart disease.
        Circulation. 2007; 116: 2734-2746
        • Crawford M.H.
        • Bernstein S.J.
        • Deedwania P.C.
        • et al.
        ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations.
        Circulation. 1999; 100: 886-893
        • Czosek R.J.
        • Anderson J.
        • Khoury P.R.
        • Knilans T.K.
        • Spar D.S.
        • Marino B.S.
        Utility of ambulatory monitoring in patients with congenital heart disease.
        Am J Cardiol. 2013; 111: 723-730
        • Rodriguez F.H.
        • Moodie D.S.
        • Neeland M.
        • Adams G.J.
        • Snyder C.S.
        Identifying arrhythmias in adults with congenital heart disease by 24-h ambulatory electrocardiography.
        Pediatr Cardiol. 2012; 33: 591-595
        • Ridley D.P.
        • Gula L.J.
        • Krahn A.D.
        • Skanes A.C.
        • Yee R.
        • Brown M.L.
        • Olson W.H.
        • Gillberg J.M.
        • Klein G.J.
        Atrial response to ventricular antitachycardia pacing discriminates mechanism of 1:1 atrioventricular tachycardia.
        J Cardiovasc Electrophysiol. 2005; 16: 601-605
        • Kenny D.
        • Chakrabarti S.
        • Ranasinghe A.
        • Chambers A.
        • Martin R.
        • Stuart G.
        Single-centre use of implantable loop recorders in patients with congenital heart disease.
        Europace. 2009; 11: 303-307
        • Mondesert B.
        • Dubin A.M.
        • Khairy P.
        Diagnostic tools for arrhythmia detection in adults with congenital heart disease and heart failure.
        Heart Fail Clin. 2014; 10: 57-67
        • Zartner P.A.
        • Toussaint-Goetz N.
        • Photiadis J.
        • Wiebe W.
        • Schneider M.B.
        Telemonitoring with implantable electronic devices in young patients with congenital heart diseases.
        Europace. 2012; 14: 1030-1037
        • Arenal A.
        • Ortiz M.
        • Peinado R.
        • Merino J.L.
        • et al.
        Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patients.
        Heart Rhythm. 2007; 4: 316-322
        • Koyak Z.
        • Achterbergh R.C.
        • de Groot J.R.
        • Berger F.
        • Koolbergen D.R.
        • Bouma B.J.
        • Lagrand W.K.
        • Hazekamp M.G.
        • Blom N.A.
        • Mulder B.J.
        Postoperative arrhythmias in adults with congenital heart disease: incidence and risk factors.
        Int J Cardiol. 2013; 169: 139-144
        • Zipes D.P.
        • Camm A.J.
        • Borggrefe M.
        • et al.
        ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
        J Am Coll Cardiol. 2006; 48: e247-e346
        • Deroubaix E.
        • Folliguet T.
        • Rucker-Martin C.
        • Dinanian S.
        • Boixel C.
        • Validire P.
        • Daniel P.
        • Capderou A.
        • Hatem S.N.
        Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability.
        J Am Coll Cardiol. 2004; 44: 1918-1926
        • Abadir S.
        • Khairy P.
        Electrophysiology and adult congenital heart disease: advances and options.
        Prog Cardiovasc Dis. 2011; 53: 281-292
        • Giannakoulas G.
        • Dimopoulos K.
        • Engel R.
        • Goktekin O.
        • Kucukdurmaz Z.
        • Vatankulu M.A.
        • Bedard E.
        • Diller G.P.
        • Papaphylactou M.
        • Francis D.P.
        • Di Mario C.
        • Gatzoulis M.A.
        Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors.
        Am J Cardiol. 2009; 103: 1445-1450
        • Khairy P.
        • Clair M.
        • Fernandes S.M.
        • Blume E.D.
        • Powell A.J.
        • Newburger J.W.
        • Landzberg M.J.
        • Mayer Jr, J.E.
        Cardiovascular outcomes after the arterial switch operation for d-transposition of the great arteries.
        Circulation. 2013; 127: 331-339
        • Khairy P.
        • Landzberg M.J.
        • Gatzoulis M.A.
        • Lucron H.
        • Lambert J.
        • Marcon F.
        • Alexander M.E.
        • Walsh E.P.
        Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study.
        Circulation. 2004; 109: 1994-2000
        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • et al.
        2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities.
        J Am Coll Cardiol. 2013; 61: e6-e75
        • Alexander M.E.
        • Walsh E.P.
        • Saul J.P.
        • Epstein M.R.
        • Triedman J.K.
        Value of programmed ventricular stimulation in patients with congenital heart disease.
        J Cardiovasc Electrophysiol. 1999; 10: 1033-1044
        • Khairy P.
        • Harris L.
        • Landzberg M.J.
        • Fernandes S.M.
        • Barlow A.
        • Mercier L.A.
        • Viswanathan S.
        • Chetaille P.
        • Gordon E.
        • Dore A.
        • Cecchin F.
        Sudden death and defibrillators in transposition of the great arteries with intra-atrial baflles: a multicenter study.
        Circ Arrhythm Electrophysiol. 2008; 1: 250-257
        • Khairy P.
        • Fernandes S.M.
        • Mayer Jr, J.E.
        • Triedman J.K.
        • Walsh E.P.
        • Lock J.E.
        • Landzberg M.J.
        Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.
        Circulation. 2008; 117: 85-92
        • Khairy P.
        • Harris L.
        • Landzberg M.J.
        • et al.
        Implantable cardioverter-defibrillators in tetralogy of Fallot.
        Circulation. 2008; 117: 363-370
        • Khairy P.
        Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective.
        Nat Clin Pract Cardiovasc Med. 2007; 4: 292-293
        • Koyak Z.
        • Kroon B.
        • de Groot J.R.
        • Wagenaar L.J.
        • van Dijk A.P.
        • Mulder B.A.
        • Van Gelder I.C.
        • Post M.C.
        • Mulder B.J.
        • Bouma B.J.
        Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias.
        Am J Cardiol. 2013; 112: 1461-1467
        • Lafuente-Lafuente C.
        • Longas-Tejero M.A.
        • Bergmann J.F.
        • Belmin J.
        Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
        Cochrane Database Syst Rev. 2012; : CD005049
        • Skanes A.C.
        • Healey J.S.
        • Cairns J.A.
        • Dorian P.
        • Gillis A.M.
        • McMurtry M.S.
        • Mitchell L.B.
        • Verma A.
        • Nattel S.
        Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
        Can J Cardiol. 2012; 28: 125-136
        • Anderson J.L.
        • Halperin J.L.
        • Albert N.M.
        • et al.
        Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2013; 61: 1935-1944
        • Akca F.
        • Bauernfeind T.
        • Witsenburg M.
        • Dabiri Abkenari L.
        • Cuypers J.A.
        • Roos-Hesselink J.W.
        • de Groot N.M.
        • Jordaens L.
        • Szili-Torok T.
        Acute and long-term outcomes of catheter ablation using remote magnetic navigation in patients with congenital heart disease.
        Am J Cardiol. 2012; 110: 409-414
        • Yap S.C.
        • Harris L.
        • Silversides C.K.
        • Downar E.
        • Chauhan V.S.
        Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery.
        J Am Coll Cardiol. 2010; 56: 1589-1596
        • Triedman J.K.
        • DeLucca J.M.
        • Alexander M.E.
        • Berul C.I.
        • Cecchin F.
        • Walsh E.P.
        Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease.
        Heart Rhythm. 2005; 2: 700-705
        • Kannankeril P.J.
        • Anderson M.E.
        • Rottman J.N.
        • Wathen M.S.
        • Fish F.A.
        Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease.
        Am J Cardiol. 2003; 92: 879-881
        • Walsh E.P.
        Arrhythmias in patients with congenital heart disease.
        Card Electrophysiol Rev. 2002; 6: 422-430
        • Triedman J.K.
        • Alexander M.E.
        • Berul C.I.
        • Bevilacqua L.M.
        • Walsh E.P.
        Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia.
        Circulation. 2001; 103: 2060-2065
        • Hebe J.
        • Hansen P.
        • Ouyang F.
        • Volkmer M.
        • Kuck K.H.
        Radiofrequency catheter ablation of tachycardia in patients with congenital heart disease.
        Pediatr Cardiol. 2000; 21: 557-575
        • Fuster V.
        • Ryden L.E.
        • Cannom D.S.
        • et al.
        2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation.
        J Am Coll Cardiol. 2011; 57: e101-e198
        • Thorne S.A.
        • Barnes I.
        • Cullinan P.
        • Somerville J.
        Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease.
        Circulation. 1999; 100: 149-154
        • Stan M.N.
        • Hess E.P.
        • Bahn R.S.
        • Warnes C.A.
        • Ammash N.M.
        • Brennan M.D.
        • Thapa P.
        • Montori V.M.
        A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease.
        J Thyroid Res. 2012; 2012: 210529
        • Wells R.
        • Khairy P.
        • Harris L.
        • Anderson C.C.
        • Balaji S.
        Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study.
        Pacing Clin Electrophysiol. 2009; 32: 1313-1318
        • Banchs J.E.
        • Baquero G.A.
        • Nickolaus M.J.
        • Wolbrette D.L.
        • Kelleman J.J.
        • Samii S.
        • Grando-Ting J.
        • Penny-Peterson E.
        • Davidson Jr, W.R.
        • Young S.K.
        • Naccarelli G.V.
        • Gonzalez M.D.
        Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
        Congenit Heart Dis. 2014; (9:221–227)
        • Szymanski P.
        • Klisiewicz A.
        • Lubiszewska B.
        • Janas J.
        • Baranska K.
        • Lipczynska M.
        • Kowalski M.
        • Rozanski J.
        • Hoffman P.
        Endogenous catecholamine levels and function of the systemic right ventricle following atrial switch.
        Int J Cardiol. 2010; 138: 81-86
        • Beaufort-Krol G.C.
        • Bink-Boelkens M.T.
        Sotalol for atrial tachycardias after surgery for congenital heart disease.
        Pacing Clin Electrophysiol. 1997; 20: 2125
        • Fish F.A.
        • Gillette P.C.
        • Benson Jr, D.W.
        The Pediatric Electrophysiology Group. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide.
        J Am Coll Cardiol. 1991; 18: 356-365
        • The Cardiac Arrhythmia Suppression Trial (CAST) Investigators
        Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
        N Engl J Med. 1989; 321: 406-412
        • The Cardiac Arrhythmia Suppression Trial II Investigators
        Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
        N Engl J Med. 1992; 327: 227-233
        • Flaker G.C.
        • Blackshear J.L.
        • McBride R.
        • Kronmal R.A.
        • Halperin J.L.
        • Hart R.G.
        • The Stroke Prevention in Atrial Fibrillation Investigators
        Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation.
        J Am Coll Cardiol. 1992; 20: 527-532
        • Stevenson W.G.
        • Stevenson L.W.
        • Middlekauff H.R.
        • Fonarow G.C.
        • Hamilton M.A.
        • Woo M.A.
        • Saxon L.A.
        • Natterson P.D.
        • Steimle A.
        • Walden J.A.
        • Tillisch J.H.
        Improving survival for patients with atrial fibrillation and advanced heart failure.
        J Am Coll Cardiol. 1996; 28: 1458-1463
        • Connolly S.J.
        • Camm A.J.
        • Halperin J.L.
        • et al.
        Dronedarone in high-risk permanent atrial fibrillation.
        N Engl J Med. 2011; 365: 2268-2276
        • Kober L.
        • Torp-Pedersen C.
        • McMurray J.J.
        • Gotzsche O.
        • Levy S.
        • Crijns H.
        • Amlie J.
        • Carlsen J.
        Increased mortality after dronedarone therapy for severe heart failure.
        N Engl J Med. 2008; 358: 2678-2687
        • Ammash N.M.
        • Phillips S.D.
        • Hodge D.O.
        • Connolly H.M.
        • Grogan M.A.
        • Friedman P.A.
        • Warnes C.A.
        • Asirvatham S.J.
        Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease.
        Int J Cardiol. 2012; 154: 270-274
        • Klein A.L.
        • Grimm R.A.
        • Black I.W.
        • Leung D.Y.
        • Chung M.K.
        • Vaughn S.E.
        • Murray R.D.
        • Miller D.P.
        • Arheart K.L.
        Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography.
        Ann Intern Med. 1997; 126: 200-209
        • Manning W.J.
        • Silverman D.I.
        • Keighley C.S.
        • Oettgen P.
        • Douglas P.S.
        Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
        J Am Coll Cardiol. 1995; 25: 1354-1361
        • Hoffmann A.
        • Chockalingam P.
        • Balint O.H.
        • Dadashev A.
        • Dimopoulos K.
        • Engel R.
        • Schmid M.
        • Schwerzmann M.
        • Gatzoulis M.A.
        • Mulder B.
        • Oechslin E.
        Cerebrovascular accidents in adult patients with congenital heart disease.
        Heart. 2010; 96: 1223-1226
      1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials.
        Arch Intern Med. 1994; 154: 1449-1457
        • Morley J.
        • Marinchak R.
        • Rials S.J.
        • Kowey P.
        Atrial fibrillation, anticoagulation, and stroke.
        Am J Cardiol. 1996; 77: 38A-44A
        • Howard P.A.
        • Duncan P.W.
        Primary stroke prevention in nonvalvular atrial fibrillation: implementing the clinical trial findings.
        Ann Pharmacother. 1997; 31: 1187-1196
        • van Walraven C.
        • Hart R.G.
        • Singer D.E.
        • Laupacis A.
        • Connolly S.
        • Petersen P.
        • Koudstaal P.J.
        • Chang Y.
        • Hellemons B.
        Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
        JAMA. 2002; 288: 2441-2448
        • Idorn L.
        • Jensen A.S.
        • Juul K.
        • Reimers J.I.
        • Johansson P.I.
        • Sorensen K.E.
        • Ostrowski S.R.
        • Sondergaard L.
        Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.
        Pediatr Cardiol. 2013; 34: 262-272
        • Giugliano R.P.
        • Ruff C.T.
        • Braunwald E.
        • et al.
        Edoxaban versus warfarin in patients with atrial fibrillation.
        N Engl J Med. 2013; 369: 2093-2104
        • Gage B.F.
        • van Walraven C.
        • Pearce L.
        • Hart R.G.
        • Koudstaal P.J.
        • Boode B.S.
        • Petersen P.
        Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
        Circulation. 2004; 110: 2287-2292
        • Roldan V.
        • Marin F.
        • Manzano-Fernandez S.
        • Gallego P.
        • Vilchez J.A.
        • Valdes M.
        • Vicente V.
        • Lip G.Y.
        The HAS-BLED score has better prediction accuracy for major bleeding than the CHADS or CHADS-VASc scores in anticoagulated patients with atrial fibrillation.
        J Am Coll Cardiol. 2013; 62: 2199-2204
        • Connolly S.J.
        • Ezekowitz M.D.
        • Yusuf S.
        • et al.
        Dabigatran versus warfarin in patients with atrial fibrillation.
        N Engl J Med. 2009; 361: 1139-1151
        • Granger C.B.
        • Alexander J.H.
        • McMurray J.J.
        • et al.
        Apixaban versus warfarin in patients with atrial fibrillation.
        N Engl J Med. 2011; 365: 981-992
        • Patel M.R.
        • Mahaffey K.W.
        • Garg J.
        • et al.
        Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
        N Engl J Med. 2011; 365: 883-891
        • Eikelboom J.W.
        • Connolly S.J.
        • Brueckmann M.
        • et al.
        Dabigatran versus warfarin in patients with mechanical heart valves.
        N Engl J Med. 2013; 369: 1206-1214
        • Van Hare G.F.
        • Lesh M.D.
        • Stanger P.
        Radiofrequency catheter ablation of supraventricular arrhythmias in patients with congenital heart disease: results and technical considerations.
        J Am Coll Cardiol. 1993; 22: 883-890
        • Levine J.C.
        • Walsh E.P.
        • Saul J.P.
        Radiofrequency ablation of accessory pathways associated with congenital heart disease including heterotaxy syndrome.
        Am J Cardiol. 1993; 72: 689-693
        • Chiou C.W.
        • Chen S.A.
        • Chiang C.E.
        • Wu T.J.
        • Tai C.T.
        • Lee S.H.
        • Cheng C.C.
        • Ueng K.C.
        • Chen C.Y.
        • Wang S.P.
        Radiofrequency catheter ablation of paroxysmal supraventricular tachycardia in patients with congenital heart disease.
        Int J Cardiol. 1995; 50: 143-151
        • Chetaille P.
        • Walsh E.P.
        • Triedman J.K.
        Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease.
        Heart Rhythm. 2004; 1: 168-173
        • Reithmann C.
        • Hoffmann E.
        • Dorwarth U.
        • Remp T.
        • Steinbeck G.
        Electroanatomical mapping for visualization of atrial activation in patients with incisional atrial tachycardias.
        Eur Heart J. 2001; 22: 237-246
        • Dorostkar P.C.
        • Cheng J.
        • Scheinman M.M.
        Electroanatomical mapping and ablation of the substrate supporting intraatrial reentrant tachycardia after palliation for complex congenital heart disease.
        Pacing Clin Electrophysiol. 1998; 21: 1810-1819
        • Kalman J.M.
        • VanHare G.F.
        • Olgin J.E.
        • Saxon L.A.
        • Stark S.I.
        • Lesh M.D.
        Ablation of “incisional” reentrant atrial tachycardia complicating surgery for congenital heart disease: use of entrainment to define a critical isthmus of conduction.
        Circulation. 1996; 93: 502-512
        • Lukac P.
        • Pedersen A.K.
        • Mortensen P.T.
        • Jensen H.K.
        • Hjortdal V.
        • Hansen P.S.
        Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate?.
        Heart Rhythm. 2005; 2: 64-72
        • Verma A.
        • Marrouche N.F.
        • Seshadri N.
        • Schweikert R.A.
        • Bhargava M.
        • Burkhardt J.D.
        • Kilicaslan F.
        • Cummings J.
        • Saliba W.
        • Natale A.
        Importance of ablating all potential right atrial flutter circuits in postcardiac surgery patients.
        J Am Coll Cardiol. 2004; 44: 409-414
        • Chan D.P.
        • Van Hare G.F.
        • Mackall J.A.
        • Carlson M.D.
        • Waldo A.L.
        Importance of atrial flutter isthmus in postoperative intra-atrial reentrant tachycardia.
        Circulation. 2000; 102: 1283-1289
        • Baker B.M.
        • Lindsay B.D.
        • Bromberg B.I.
        • Frazier D.W.
        • Cain M.E.
        • Smith J.M.
        Catheter ablation of clinical intraatrial reentrant tachycardias resulting from previous atrial surgery: localizing and transecting the critical isthmus.
        J Am Coll Cardiol. 1996; 28: 411-417
        • Kanter R.J.
        • Papagiannis J.
        • Carboni M.P.
        • Ungerleider R.M.
        • Sanders W.E.
        • Wharton J.M.
        Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries.
        J Am Coll Cardiol. 2000; 35: 428-441
        • Triedman J.K.
        • Bergau D.M.
        • Saul J.P.
        • Epstein M.R.
        • Walsh E.P.
        Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease.
        J Am Coll Cardiol. 1997; 30: 1032-1038
        • Triedman J.K.
        • Jenkins K.J.
        • Colan S.D.
        • Saul J.P.
        • Walsh E.P.
        Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping.
        J Cardiovasc Electrophysiol. 1997; 8: 259-270
        • de Groot N.M.
        • Atary J.Z.
        • Blom N.A.
        • Schalij M.J.
        Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences.
        Circ Arrhythm Electrophysiol. 2010; 3: 148-154
        • Drago F.
        • Russo M.S.
        • Marazzi R.
        • Salerno-Uriarte J.A.
        • Silvetti M.S.
        • De Ponti R.
        Atrial tachycardias in patients with congenital heart disease: a minimally invasive simplified approach in the use of three-dimensional electroanatomic mapping.
        Europace. 2011; 13: 689-695
        • Zachariah J.P.
        • Walsh E.P.
        • Triedman J.K.
        • Berul C.I.
        • Cecchin F.
        • Alexander M.E.
        • Bevilacqua L.M.
        Multiple accessory pathways in the young: the impact of structural heart disease.
        Am Heart J. 2013; 165: 87-92
        • Leonelli F.M.
        • Tomassoni G.
        • Richey M.
        • Natale A.
        Ablation of incisional atrial tachycardias using a three-dimensional nonfluoroscopic mapping system.
        Pacing Clin Electrophysiol. 2001; 24: 1653-1659
        • Peichl P.
        • Kautzner J.
        • Cihak R.
        • Vancura V.
        • Bytesnik J.
        Clinical application of electroanatomical mapping in the characterization of “incisional” atrial tachycardias.
        Pacing Clin Electrophysiol. 2003; 26: 420-425
        • Triedman J.K.
        • Alexander M.E.
        • Love B.A.
        • Collins K.K.
        • Berul C.I.
        • Bevilacqua L.M.
        • Walsh E.P.
        Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease.
        J Am Coll Cardiol. 2002; 39: 1827-1835
        • Tanner H.
        • Lukac P.
        • Schwick N.
        • Fuhrer J.
        • Pedersen A.K.
        • Hansen P.S.
        • Delacretaz E.
        Irrigated-tip catheter ablation of intraatrial reentrant tachycardia in patients late after surgery of congenital heart disease.
        Heart Rhythm. 2004; 1: 268-275
        • Blaufox A.D.
        • Numan M.T.
        • Laohakunakorn P.
        • Knick B.
        • Paul T.
        • Saul J.P.
        Catheter tip cooling during radiofrequency ablation of intra-atrial reentry: effects on power, temperature, and impedance.
        J Cardiovasc Electrophysiol. 2002; 13: 783-787
        • Khairy P.
        • Seslar S.P.
        • Triedman J.K.
        • Cecchin F.
        Ablation of atrioventricular nodal reentrant tachycardia in tricuspid atresia.
        J Cardiovasc Electrophysiol. 2004; 15: 719-722
        • Roten L.
        • Lukac P.
        • De Groot N.
        • Nielsen J.C.
        • Szili-Torok T.
        • Jensen H.K.
        • Zimmermann M.
        • Delacrétaz E.
        Catheter ablation of arrhythmias in Ebstein’s anomaly: a multicenter study.
        J Cardiovasc Electrophysiol. 2011; 22: 1391-1396
        • Khairy P.
        • Mercier L.A.
        • Dore A.
        • Dubuc M.
        Partial atrioventricular canal defect with inverted atrioventricular nodal input into an inferiorly displaced atrioventricular node.
        Heart Rhythm. 2007; 4: 355-358
        • Philip F.
        • Muhammad K.I.
        • Agarwal S.
        • Natale A.
        • Krasuski R.A.
        Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease.
        Congenit Heart Dis. 2012; 7: 392-399
        • Shivapour J.K.
        • Sherwin E.D.
        • Alexander M.E.
        • Cecchin F.
        • May D.Y.
        • Triedman J.K.
        • Marx G.R.
        • del Nido P.
        • Walsh E.P.
        The utility of preoperative electrophysiological studies and reveal implantation in patients with Ebstein’s anomaly undergoing Cone procedure.
        Heart Rhythm. 2014; (182–186)
        • Bae E.J.
        • Ban J.E.
        • Lee J.A.
        • Jin S.M.
        • Noh C.I.
        • Choi J.Y.
        • Yun Y.S.
        Pediatric radiofrequency catheter ablation: results of initial 100 consecutive cases including congenital heart anomalies.
        J Korean Med Sci. 2005; 20: 740-746
        • Friedman R.A.
        • Will J.C.
        • Fenrich A.L.
        • Kertesz N.J.
        Atrioventricular junction ablation and pacemaker therapy in patients with drug-resistant atrial tachyarrhythmias after the Fontan operation.
        J Cardiovasc Electrophysiol. 2005; 16: 24-29
        • Calkins H.
        • Epstein A.
        • Packer D.
        • et al.
        • Cooled RF Multi Center Investigators Group
        Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study.
        J Am Coll Cardiol. 2000; 35: 1905-1914
        • Furushima H.
        • Chinushi M.
        • Sugiura H.
        • Komura S.
        • Tanabe Y.
        • Watanabe H.
        • Washizuka T.
        • Aizawa Y.
        Ventricular tachycardia late after repair of congenital heart disease: efficacy of combination therapy with radiofrequency catheter ablation and class III antiarrhythmic agents and long-term outcome.
        J Electrocardiol. 2006; 39: 219-224
        • Zeppenfeld K.
        • Schalij M.J.
        • Bartelings M.M.
        • Tedrow U.B.
        • Koplan B.A.
        • Soejima K.
        • Stevenson W.G.
        Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus.
        Circulation. 2007; 116: 2241-2252
        • Kay R.
        • Estioko M.
        • Wiener I.
        Primary sick sinus syndrome as an indication for chronic pacemaker therapy in young adults: incidence, clinical features, and long-term evaluation.
        Am Heart J. 1982; 103: 338
        • Rasmussen K.
        Chronic sinus node disease: natural course and indications for pacing.
        Eur Heart J. 1981; 2: 455-459
        • Linde-Edelstam C.
        • Nordlander R.
        • Pehrsson S.K.
        • Ryden L.
        A double-blind study of submaximal exercise tolerance and variation in paced rate in atrial synchronous compared to activity sensor modulated ventricular pacing.
        Pacing Clin Electrophysiol. 1992; 15: 905-915
        • Olshansky B.
        • Day J.D.
        • Moore S.
        • Gering L.
        • Rosenbaum M.
        • McGuire M.
        • Brown S.
        • Lerew D.R.
        Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study.
        Circulation. 2007; 115: 9-16
        • Sweeney M.O.
        • Prinzen F.W.
        A new paradigm for physiologic ventricular pacing.
        J Am Coll Cardiol. 2006; 47: 282-288
        • Sweeney M.O.
        • Wathen M.S.
        • Volosin K.
        • Abdalla I.
        • DeGroot P.J.
        • Otterness M.F.
        • Stark A.J.
        Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
        Circulation. 2005; 111: 2898-2905
        • Gillis A.M.
        • Purerfellner H.
        • Israel C.W.
        • Sunthorn H.
        • Kacet S.
        • Anelli-Monti M.
        • Tang F.
        • Young M.
        • Boriani G.
        Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.
        Pacing Clin Electrophysiol. 2006; 29: 697-705
        • Sweeney M.O.
        • Bank A.J.
        • Nsah E.
        • Koullick M.
        • Zeng Q.C.
        • Hettrick D.
        • Sheldon T.
        • Lamas G.A.
        Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
        N Engl J Med. 2007; 357: 1000-1008
        • Barold S.S.
        Indications for permanent cardiac pacing in first-degree AV block: class I, II, or III?.
        Pacing Clin Electrophysiol. 1996; 19: 747-751
        • Kim Y.H.
        • O’Nunain S.
        • Trouton T.
        • Sosa-Suarez G.
        • Levine R.A.
        • Garan H.
        • Ruskin J.N.
        Pseudo-pacemaker syndrome following inadvertent fast pathway ablation for atrioventricular nodal reentrant tachycardia.
        J Cardiovasc Electrophysiol. 1993; 4: 178-182
        • Strasberg B.
        • Amat Y.L.F.
        • Dhingra R.C.
        • Palileo E.
        • Swiryn S.
        • Bauernfeind R.
        • Wyndham C.
        • Rosen K.M.
        Natural history of chronic second-degree atrioventricular nodal block.
        Circulation. 1981; 63: 1043-1049
      2. Recommendations for pacemaker prescription for symptomatic bradycardia: Report of a working party of the British Pacing and Electrophysiology Group.
        Br Heart J. 1991; 66: 185-191
        • Kastor J.A.
        Atrioventricular block (first of two parts).
        N Engl J Med. 1975; 292: 462-465
        • Michaelsson M.
        • Jonzon A.
        • Riesenfeld T.
        Isolated congenital complete atrioventricular block in adult life: a prospective study.
        Circulation. 1995; 92: 442-449
        • Villain E.
        • Coastedoat-Chalumeau N.
        • Marijon E.
        • Boudjemline Y.
        • Piette J.C.
        • Bonnet D.
        Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status.
        J Am Coll Cardiol. 2006; 48: 1682-1687
        • Moak J.P.
        • Barron K.S.
        • Hougen T.J.
        • et al.
        Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela.
        J Am Coll Cardiol. 2001; 37: 238-242
        • Kim M.H.
        • Deeb G.M.
        • Eagle K.A.
        • et al.
        Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation.
        Am J Cardiol. 2001; 87 (A10): 649-651
        • Glikson M.
        • Dearani J.A.
        • Hyberger L.K.
        • Schaff H.V.
        • Hammill S.C.
        • Hayes D.L.
        Indications, effectiveness, and long-term dependency in permanent pacing after cardiac surgery.
        Am J Cardiol. 1997; 80: 1309-1313
        • Koplan B.A.
        • Stevenson W.G.
        • Epstein L.M.
        • Aranki S.F.
        • Maisel W.H.
        Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery.
        J Am Coll Cardiol. 2003; 41: 795-801
        • Cohen M.I.
        • Vetter V.L.
        • Wernovsky G.
        • Bush D.M.
        • Gaynor J.W.
        • Iyer V.R.
        • Spray T.L.
        • Tanel R.E.
        • Rhodes L.A.
        Epicardial pacemaker implantation and follow-up in patients with a single ventricle after the Fontan operation.
        J Thorac Cardiovasc Surg. 2001; 121: 804-811
        • Silka M.J.
        • Manwill J.R.
        • Kron J.
        • McAnulty J.H.
        Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates.
        Am J Cardiol. 1990; 65: 488-493
        • Stephenson E.A.
        • Casavant D.
        • Tuzi J.
        • Alexander M.E.
        • Law I.
        • Serwer G.
        • Strieper M.
        • Walsh E.P.
        • Berul C.I.
        Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease.
        Am J Cardiol. 2003; 92: 871-876
        • Rhodes L.A.
        • Walsh E.P.
        • Gamble W.J.
        • Triedman J.K.
        • Saul J.P.
        Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease.
        Pacing Clin Electrophysiol. 1995; 18: 1005-1016
        • Gillette P.C.
        • Zeigler V.L.
        • Case C.L.
        • Harold M.
        • Buckles D.S.
        Atrial antitachycardia pacing in children and young adults.
        Am Heart J. 1991; 122: 844-849
        • McComb J.M.
        • Jameson S.
        • Bexton R.S.
        Atrial antitachycardia pacing in patients with supraventricular tachycardia: clinical experience with the Intertach pacemaker.
        Pacing Clin Electrophysiol. 1990; 13: 1948-1954
        • Dewey R.C.
        • Capeless M.A.
        • Levy A.M.
        Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block.
        N Engl J Med. 1987; 316: 835-839
        • Sholler G.F.
        • Walsh E.P.
        Congenital complete heart block in patients without anatomic cardiac defects.
        Am Heart J. 1989; 118: 1193-1198
        • Shaw D.B.
        • Holman R.R.
        • Gowers J.I.
        Survival in sinoatrial disorder (sick-sinus syndrome).
        Br Med J. 1980; 280: 139-141
        • Krongrad E.
        Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects.
        Circulation. 1978; 57: 867-870
        • Khairy P.
        • Landzberg M.J.
        • Gatzoulis M.A.
        • Mercier L.A.
        • Fernandes S.M.
        • Cote J.M.
        • Lavoie J.P.
        • Fournier A.
        • Guerra P.G.
        • Frogoudaki A.
        • Walsh E.P.
        • Dore A.
        Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study.
        Circulation. 2006; 113: 2391-2397
        • Berul C.I.
        • Van Hare G.F.
        • Kertesz N.J.
        • Dubin A.M.
        • Cecchin F.
        • Collins K.K.
        • Cannon B.C.
        • Alexander M.E.
        • Triedman J.K.
        • Walsh E.P.
        • Friedman R.A.
        Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
        J Am Coll Cardiol. 2008; 51: 1685-1691
        • Alexander M.E.
        • Cecchin F.
        • Walsh E.P.
        • Triedman J.K.
        • Bevilacqua L.M.
        • Berul C.I.
        Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.
        J Cardiovasc Electrophysiol. 2004; 15: 72-76
        • Silka M.J.
        • Kron J.
        • Dunnigan A.
        • Dick II, M.
        The Pediatric Electrophysiology Society. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients.
        Circulation. 1993; 87: 800-807
        • Koyak Z.
        • de Groot J.R.
        • Van Gelder I.C.
        • Bouma B.J.
        • van Dessel P.F.
        • Budts W.
        • van Erven L.
        • van Dijk A.P.
        • Wilde A.A.
        • Pieper P.G.
        • Sieswerda G.T.
        • Mulder B.J.
        Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?.
        Circ Arrhythm Electrophysiol. 2012; 5: 101-110
        • Karamlou T.
        • Silber I.
        • Lao R.
        • McCrindle B.W.
        • Harris L.
        • Downar E.
        • Webb G.D.
        • Colman J.M.
        • Van Arsdell G.S.
        • Williams W.G.
        Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery.
        Ann Thorac Surg. 2006; 81 (discussion 1793): 1786-1793
        • Miyazaki A.
        • Sakaguchi H.
        • Ohuchi H.
        • Matsuoka M.
        • Komori A.
        • Yamamoto T.
        • Yasuda K.
        • Satomi K.
        • Hoashi T.
        • Kamakura S.
        • Yamada O.
        Efficacy of hemodynamic-based management of tachyarrhythmia after repair of tetralogy of Fallot.
        Circ J. 2012; 76: 2855-2862
        • Kriebel T.
        • Saul J.P.
        • Schneider H.
        • Sigler M.
        • Paul T.
        Noncontact mapping and radiofrequency catheter ablation of fast and hemodynamically unstable ventricular tachycardia after surgical repair of tetralogy of Fallot.
        J Am Coll Cardiol. 2007; 50: 2162-2168
        • Bardy G.H.
        • Lee K.L.
        • Mark D.B.
        • et al.
        Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
        N Engl J Med. 2005; 352: 225-237
        • Kadish A.
        • Dyer A.
        • Daubert J.P.
        • Quigg R.
        • Estes N.A.
        • Anderson K.P.
        • Calkins H.
        • Hoch D.
        • Goldberger J.
        • Shalaby A.
        • Sanders W.E.
        • Schaechter A.
        • Levine J.H.
        Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
        N Engl J Med. 2004; 350: 2151-2158
        • Desai A.S.
        • Fang J.C.
        • Maisel W.H.
        • Baughman K.L.
        Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
        JAMA. 2004; 292: 2874-2879
        • Ghai A.
        • Silversides C.
        • Harris L.
        • Webb G.D.
        • Siu S.C.
        • Therrien J.
        Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot.
        J Am Coll Cardiol. 2002; 40: 1675-1680
        • Silka M.J.
        • Bar-Cohen Y.
        Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator.
        Circ Arrhythm Electrophysiol. 2008; 1: 298-306
        • Witte K.K.
        • Pepper C.B.
        • Cowan J.C.
        • Thomson J.D.
        • English K.M.
        • Blackburn M.E.
        Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot.
        Europace. 2008; 10: 926-930
        • Gatzoulis M.A.
        • Balaji S.
        • Webber S.A.
        • Siu S.C.
        • Hokanson J.S.
        • Poile C.
        • Rosenthal M.
        • Nakazawa M.
        • Moller J.H.
        • Gillette P.C.
        • Webb G.D.
        • Redington A.N.
        Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.
        Lancet. 2000; 356: 975-981
        • Khairy P.
        • Aboulhosn J.
        • Gurvitz M.Z.
        • et al.
        Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study.
        Circulation. 2010; 122: 868-875
        • Valente A.M.
        • Gauvreau K.
        • Egidy Assenza G.
        • et al.
        Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.
        Heart. 2014; 100: 247-253
        • Berul C.I.
        • Hill S.L.
        • Geggel R.L.
        • Hijazi Z.M.
        • Marx G.R.
        • Rhodes J.
        • Walsh K.A.
        • Fulton D.R.
        Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children.
        J Cardiovasc Electrophysiol. 1997; 8: 1349-1356
        • Babu-Narayan S.V.
        • Kilner P.J.
        • Li W.
        • Moon J.C.
        • Goktekin O.
        • Davlouros P.A.
        • Khan M.
        • Ho S.Y.
        • Pennell D.J.
        • Gatzoulis M.A.
        Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome.
        Circulation. 2006; 113: 405-413
        • Schwerzmann M.
        • Salehian O.
        • Harris L.
        • Siu S.C.
        • Williams W.G.
        • Webb G.D.
        • Colman J.M.
        • Redington A.
        • Silversides C.K.
        Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries.
        Eur Heart J. 2009; 30: 1873-1879
        • Janousek J.
        • Paul T.
        • Luhmer I.
        • Wilken M.
        • Hruda J.
        • Kallfelz H.C.
        Atrial baffle procedures for complete transposition of the great arteries: natural course of sinus node dysfunction and risk factors for dysrhythmias and sudden death.
        Z Kardiol. 1994; 83: 933-938
        • Kammeraad J.A.
        • van Deurzen C.H.
        • Sreeram N.
        • Bink-Boelkens M.T.
        • Ottenkamp J.
        • Helbing W.A.
        • Lam J.
        • Sobotka-Plojhar M.A.
        • Daniels O.
        • Balaji S.
        Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries.
        J Am Coll Cardiol. 2004; 44: 1095-1102
        • Triedman J.K.
        Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
        Circ Arrhythm Electrophysiol. 2008; 1 (discussion 316): 307-316
        • Graham Jr, T.P.
        • Bernard Y.D.
        • Mellen B.G.
        • et al.
        Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study.
        J Am Coll Cardiol. 2000; 36: 255-261
        • Connolly S.J.
        • Gent M.
        • Roberts R.S.
        • Dorian P.
        • Roy D.
        • Sheldon R.S.
        • Mitchell L.B.
        • Green M.S.
        • Klein G.J.
        • O’Brien B.
        Canadian Implantable Defibrillator Study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
        Circulation. 2000; 101: 1297-1302
        • Dubin A.M.
        • Berul C.I.
        • Bevilacqua L.M.
        • et al.
        The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation.
        J Card Fail. 2003; 9: 375-379
        • Prystowsky E.N.
        • Padanilam B.J.
        • Joshi S.
        • Fogel R.I.
        Ventricular arrhythmias in the absence of structural heart disease.
        J Am Coll Cardiol. 2012; 59: 1733-1744
        • Rajdev A.
        • Garan H.
        • Biviano A.
        Arrhythmias in pulmonary arterial hypertension.
        Prog Cardiovasc Dis. 2012; 55: 180-186
        • Tonelli A.R.
        • Arelli V.
        • Minai O.A.
        • Newman J.
        • Bair N.
        • Heresi G.A.
        • Dweik R.A.
        Causes and circumstances of death in pulmonary arterial hypertension.
        Am J Respir Crit Care Med. 2013; 188: 365-369
        • Dubin A.M.
        • Janousek J.
        • Rhee E.
        • et al.
        Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study.
        J Am Coll Cardiol. 2005; 46: 2277-2283
        • Cecchin F.
        • Frangini P.A.
        • Brown D.W.
        • Fynn-Thompson F.
        • Alexander M.E.
        • Triedman J.K.
        • Gauvreau K.
        • Walsh E.P.
        • Berul C.I.
        Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution.
        J Cardiovasc Electrophysiol. 2009; 20: 58-65
        • Janousek J.
        • Gebauer R.A.
        • Abdul-Khaliq H.
        • et al.
        Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates.
        Heart. 2009; 95: 1165-1171
        • Khairy P.
        • Fournier A.
        • Thibault B.
        • Dubuc M.
        • Therien J.
        • Vobecky S.J.
        Cardiac resynchronization therapy in congenital heart disease.
        Int J Cardiol. 2006; 109: 160-168
        • Bristow M.R.
        • Saxon L.A.
        • Boehmer J.
        • Krueger S.
        • Kass D.A.
        • De Marco T.
        • Carson P.
        • DiCarlo L.
        • DeMets D.
        • White B.G.
        • DeVries D.W.
        • Feldman A.M.
        Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
        N Engl J Med. 2004; 350: 2140-2150
        • Cleland J.G.
        • Daubert J.C.
        • Erdmann E.
        • Freemantle N.
        • Gras D.
        • Kappenberger L.
        • Tavazzi L.
        The effect of cardiac resynchronization on morbidity and mortality in heart failure.
        N Engl J Med. 2005; 352: 1539-1549
        • Linde C.
        • Abraham W.T.
        • Gold St, M.R.
        • John Sutton M.
        • Ghio S.
        • Daubert C.
        Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
        J Am Coll Cardiol. 2008; 52: 1834-1843
        • Moss A.J.
        • Hall W.J.
        • Cannom D.S.
        • et al.
        Cardiac-resynchronization therapy for the prevention of heart-failure events.
        N Engl J Med. 2009; 361: 1329-1338
        • Tang A.S.
        • Wells G.A.
        • Talajic M.
        • et al.
        Cardiac-resynchronization therapy for mild-to-moderate heart failure.
        N Engl J Med. 2010; 363: 2385-2395
        • Abraham W.T.
        • Fisher W.G.
        • Smith A.L.
        • et al.
        Cardiac resynchronization in chronic heart failure.
        N Engl J Med. 2002; 346: 1845-1853
        • Janousek J.
        • Tomek V.
        • Chaloupecky V.A.
        • Reich O.
        • Gebauer R.A.
        • Kautzner J.
        • Hucin B.
        Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure.
        J Am Coll Cardiol. 2004; 44: 1927-1931
        • Jauvert G.
        • Rousseau-Paziaud J.
        • Villain E.
        • Iserin L.
        • Hidden-Lucet F.
        • Ladouceur M.
        • Sidi D.
        Effects of cardiac resynchronization therapy on echocardiographic indices, functional capacity, and clinical outcomes of patients with a systemic right ventricle.
        Europace. 2009; 11: 184-1890
        • van Geldorp I.E.
        • Bordachar P.
        • Lumens J.
        • de Guillebon M.
        • Whinnett Z.I.
        • Prinzen F.W.
        • Haissaguerre M.
        • Delhaas T.
        • Thambo J.B.
        Acute hemodynamic benefits of biventricular and single-site systemic ventricular pacing in patients with a systemic right ventricle.
        Heart Rhythm. 2013; 10: 676-682
        • Horovitz A.
        • De Guillebon M.
        • van Geldorp I.E.
        • Bordachar P.
        • Roubertie F.
        • Iriart X.
        • Douard H.
        • Haissaguerre M.
        • Thambo J.B.
        Effects of nonsystemic ventricular pacing in patients with transposition of the great arteries and atrial redirection.
        J Cardiovasc Electrophysiol. 2012; 23: 766-770
        • Manolis A.S.
        The deleterious consequences of right ventricular apical pacing: time to seek alternate site pacing.
        Pacing Clin Electrophysiol. 2006; 29: 298-315
        • Tantengco M.V.
        • Thomas R.L.
        • Karpawich P.P.
        Left ventricular dysfunction after long-term right ventricular apical pacing in the young.
        J Am Coll Cardiol. 2001; 37: 2093-2100
        • Thambo J.B.
        • Bordachar P.
        • Garrigue S.
        • et al.
        Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing.
        Circulation. 2004; 110: 3766-3772
        • Karpawich P.P.
        • Rabah R.
        • Haas J.E.
        Altered cardiac histology following apical right ventricular pacing in patients with congenital atrioventricular block.
        Pacing Clin Electrophysiol. 1999; 22: 1372-1377
        • Kim J.J.
        • Friedman R.A.
        • Eidem B.W.
        • Cannon B.C.
        • Arora G.
        • Smith E.O.
        • Fenrich A.L.
        • Kertesz N.J.
        Ventricular function and long-term pacing in children with congenital complete atrioventricular block.
        J Cardiovasc Electrophysiol. 2007; 18: 373-377
        • Gebauer R.A.
        • Tomek V.
        • Salameh A.
        • Marek J.
        • Chaloupecky V.
        • Gebauer R.
        • Matejka T.
        • Vojtovic P.
        • Janousek J.
        Predictors of left ventricular remodelling and failure in right ventricular pacing in the young.
        Eur Heart J. 2009; 30: 1097-1104
        • Vanagt W.Y.
        • Verbeek X.A.
        • Delhaas T.
        • Gewillig M.
        • Mertens L.
        • Wouters P.
        • Meyns B.
        • Daenen W.J.
        • Prinzen F.W.
        Acute hemodynamic benefit of left ventricular apex pacing in children.
        Ann Thorac Surg. 2005; 79: 932-936
        • Moak J.P.
        • Hasbani K.
        • Ramwell C.
        • Freedenberg V.
        • Berger J.T.
        • DiRusso G.
        • Callahan P.
        Dilated cardiomyopathy following right ventricular pacing for AV block in young patients: resolution after upgrading to biventricular pacing systems.
        J Cardiovasc Electrophysiol. 2006; 17: 1068-1071
        • Wilkoff B.L.
        • Cook J.R.
        • Epstein A.E.
        • Greene H.L.
        • Hallstrom A.P.
        • Hsia H.
        • Kutalek S.P.
        • Sharma A.
        Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
        JAMA. 2002; 288: 3115-3123
        • Adelstein E.
        • Schwartzman D.
        • Gorcsan III, J.
        • Saba S.
        Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization.
        J Cardiovasc Electrophysiol. 2011; 22: 905-911
        • Vatankulu M.A.
        • Goktekin O.
        • Kaya M.G.
        • Ayhan S.
        • Kucukdurmaz Z.
        • Sutton R.
        • Henein M.
        Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
        Am J Cardiol. 2009; 103: 1280-1284
        • van Geldorp I.E.
        • Delhaas T.
        • Gebauer R.A.
        • et al.
        Impact of the permanent ventricular pacing site on left ventricular function in children: a retrospective multicentre survey.
        Heart. 2011; 97: 2051-2055
        • Gebauer R.A.
        • Tomek V.
        • Kubus P.
        • Razek V.
        • Matejka T.
        • Salameh A.
        • Kostelka M.
        • Janousek J.
        Differential effects of the site of permanent epicardial pacing on left ventricular synchrony and function in the young: implications for lead placement.
        Europace. 2009; 11: 1654-1659
        • Tomaske M.
        • Breithardt O.A.
        • Bauersfeld U.
        Preserved cardiac synchrony and function with single-site left ventricular epicardial pacing during mid-term follow-up in paediatric patients.
        Europace. 2009; 11: 1168-1676
        • Janousek J.
        • van Geldorp I.E.
        • Krupickova S.
        • et al.
        Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study.
        Circulation. 2013; 127: 613-623
        • Doshi R.N.
        • Daoud E.G.
        • Fellows C.
        • Turk K.
        • Duran A.
        • Hamdan M.H.
        • Pires L.A.
        Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).
        J Cardiovasc Electrophysiol. 2005; 16: 1160-1165
        • van Geldorp I.E.
        • Vanagt W.Y.
        • Bauersfeld U.
        • Tomaske M.
        • Prinzen F.W.
        • Delhaas T.
        Chronic left ventricular pacing preserves left ventricular function in children.
        Pediatr Cardiol. 2009; 30: 125-132
        • van Geldorp I.E.
        • Vernooy K.
        • Delhaas T.
        • Prins M.H.
        • Crijns H.J.
        • Prinzen F.W.
        • Dijkman B.
        Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy.
        Europace. 2010; 12: 223-229
        • Tomaske M.
        • Breithardt O.A.
        • Balmer C.
        • Bauersfeld U.
        Successful cardiac resynchronization with single-site left ventricular pacing in children.
        Int J Cardiol. 2009; 136: 136-143
        • Dubin A.M.
        • Feinstein J.A.
        • Reddy V.M.
        • Hanley F.L.
        • Van Hare G.F.
        • Rosenthal D.N.
        Electrical resynchronization: a novel therapy for the failing right ventricle.
        Circulation. 2003; 107: 2287-2289
        • Janousek J.
        • Vojtovic P.
        • Hucin B.
        • Tlaskal T.
        • Gebauer R.A.
        • Gebauer R.
        • Matejka T.
        • Marek J.
        • Reich O.
        Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects.
        Am J Cardiol. 2001; 88: 145-152
        • Thambo J.B.
        • Dos Santos P.
        • De Guillebon M.
        • et al.
        Biventricular stimulation improves right and left ventricular function after tetralogy of Fallot repair: acute animal and clinical studies.
        Heart Rhythm. 2010; 7: 344-350
        • Thambo J.B.
        • De Guillebon M.
        • Xhaet O.
        • Dos Santos P.
        • Roubertie F.
        • Labrousse L.
        • Iriart X.
        • Ploux S.
        • Haissaguerre M.
        • Bordachar P.
        Biventricular pacing in patients with tetralogy of Fallot: non-invasive epicardial mapping and clinical impact.
        Int J Cardiol. 2013; 163: 170-174
        • Thibault B.
        • Harel F.
        • Ducharme A.
        • et al.
        Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the evaluation of resynchronization therapy for heart failure (LESSER-EARTH) trial.
        Circulation. 2013; 127: 873-881
        • Goldstein N.E.
        • Lampert R.
        • Bradley E.
        • Lynn J.
        • Krumholz H.M.
        Management of implantable cardioverter defibrillators in end-of-life care.
        Ann Intern Med. 2004; 141: 835-838
        • Mavroudis C.
        • Deal B.J.
        • Backer C.L.
        • Stewart R.D.
        • Franklin W.H.
        • Tsao S.
        • Ward K.M.
        • DeFreitas R.A.
        J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes.
        Ann Thorac Surg. 2007; 84 (discussion 1465–1466): 1457-1465
        • Stulak J.M.
        • Dearani J.A.
        • Burkhart H.M.
        • Park S.J.
        • Suri R.M.
        • Schaff H.V.
        The surgical treatment of concomitant atrial arrhythmias during redo cardiac operations.
        Ann Thorac Surg. 2012; 94 (discussion 1900): 1894-1899
        • Harrison D.A.
        • Harris L.
        • Siu S.C.
        • MacLoghlin C.J.
        • Connelly M.S.
        • Webb G.D.
        • Downar E.
        • McLaughlin P.R.
        • Williams W.G.
        Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot.
        J Am Coll Cardiol. 1997; 30: 1368-1373
        • Holst K.A.
        • Dearani J.A.
        • Burkhart H.M.
        • Connolly H.M.
        • Warnes C.A.
        • Li Z.
        • Schaff H.V.
        Reoperative multivalve surgery in adult congenital heart disease.
        Ann Thorac Surg. 2013; 95: 1383-1389
        • Mascio C.E.
        • Pasquali S.K.
        • Jacobs J.P.
        • Jacobs M.L.
        • Austin III, E.H.
        Outcomes in adult congenital heart surgery: analysis of the Society of Thoracic Surgeons database.
        J Thorac Cardiovasc Surg. 2011; 142: 1090-1097
        • Zomer A.C.
        • Verheugt C.L.
        • Vaartjes I.
        • Uiterwaal C.S.
        • Langemeijer M.M.
        • Koolbergen D.R.
        • Hazekamp M.G.
        • van Melle J.P.
        • Konings T.C.
        • Bellersen L.
        • Grobbee D.E.
        • Mulder B.J.
        Surgery in adults with congenital heart disease.
        Circulation. 2011; 124: 2195-2201
        • Cohen M.I.
        • Triedman J.K.
        • Cannon B.C.
        • et al.
        PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern.
        Heart Rhythm. 2012; 9: 1006-1024
        • Van Hare G.F.
        Radiofrequency ablation of accessory pathways associated with congenital heart disease.
        Pacing Clin Electrophysiol. 1997; 20: 2077
        • Deal B.J.
        • Mavroudis C.
        • Backer C.L.
        The role of concomitant arrhythmia surgery in patients undergoing repair of congenital heart disease.
        Pacing Clin Electrophysiol. 2008; 31: S13-S16
        • Sciarra L.
        • Rebecchi M.
        • De Ruvo E.
        • De Luca L.
        • Zuccaro L.M.
        • Fagagnini A.
        • Coro L.
        • Allocca G.
        • Lioy E.
        • Delise P.
        • Calo L.
        How many atrial fibrillation ablation candidates have an underlying supraventricular tachycardia previously unknown? Efficacy of isolated triggering arrhythmia ablation.
        Europace. 2010; 12: 1707-1712
        • Cox J.L.
        • Jaquiss R.D.
        • Schuessler R.B.
        • Boineau J.P.
        Modification of the Maze procedure for atrial flutter and atrial fibrillation, II: Surgical technique of the Maze III procedure.
        J Thorac Cardiovasc Surg. 1995; 110: 485-495
        • Deal B.J.
        • Mavroudis C.
        • Backer C.L.
        • Buck S.H.
        • Johnsrude C.
        Comparison of anatomic isthmus block with the modified right atrial Maze procedure for late atrial tachycardia in Fontan patients.
        Circulation. 2002; 106: 575-579
        • Takahashi K.
        • Fynn-Thompson F.
        • Cecchin F.
        • Khairy P.
        • del Nido P.
        • Triedman J.K.
        Clinical outcomes of Fontan conversion surgery with and without associated arrhythmia intervention.
        Int J Cardiol. 2009; 137: 260-266
        • Aboulhosn J.
        • Williams R.
        • Shivkumar K.
        • Barkowski R.
        • Plunkett M.
        • Miner P.
        • Houser L.
        • Laks H.
        • Reemtsen B.
        • Shannon K.
        • Child J.
        Arrhythmia recurrence in adult patients with single ventricle physiology following surgical Fontan conversion.
        Congenit Heart Dis. 2010; 5: 430-434
        • Setty S.P.
        • Finucane K.
        • Skinner J.R.
        • Kerr A.R.
        Extracardiac conduit with a limited Maze procedure for the failing Fontan with atrial tachycardias.
        Ann Thorac Surg. 2002; 74: 1992-1997
        • Backer C.L.
        • Tsao S.
        • Deal B.J.
        • Mavroudis C.
        Maze procedure in single ventricle patients.
        Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2008; : 44-48
        • Beukema W.P.
        • Sie H.T.
        • Misier A.R.
        • Delnoy P.P.
        • Wellens H.J.
        • Elvan A.
        Intermediate to long-term results of radiofrequency modified Maze procedure as an adjunct to open-heart surgery.
        Ann Thorac Surg. 2008; 86: 1409-1414
        • Damiano Jr, R.J.
        • Badhwar V.
        • Acker M.A.
        • Veeragandham R.S.
        • Kress D.C.
        • Robertson J.O.
        • Sundt T.M.
        The CURE-AF trial: a prospective, multicenter trial of irrigated radiofrequency ablation for the treatment of persistent atrial fibrillation during concomitant cardiac surgery.
        Heart Rhythm. 2014; 11: 39-45
        • Gillinov A.M.
        • Saltman A.E.
        Ablation of atrial fibrillation with concomitant cardiac surgery.
        Semin Thorac Cardiovasc Surg. 2007; 19: 25-32
        • Kong M.H.
        • Lopes R.D.
        • Piccini J.P.
        • Hasselblad V.
        • Bahnson T.D.
        • Al-Khatib S.M.
        Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials.
        Cardiovasc Ther. 2010; 28: 311-326
        • Reston J.T.
        • Shuhaiber J.H.
        Meta-analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation.
        Eur J Cardiothorac Surg. 2005; 28: 724-730
        • Gutierrez S.D.
        • Earing M.G.
        • Singh A.K.
        • Tweddell J.S.
        • Bartz P.J.
        Atrial tachyarrhythmias and the Cox-Maze procedure in congenital heart disease.
        Congenit Heart Dis. 2013; 8: 434-439
        • Stulak J.M.
        • Dearani J.A.
        • Puga F.J.
        • Zehr K.J.
        • Schaff H.V.
        • Danielson G.K.
        Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease.
        Ann Thorac Surg. 2006; 81 (discussion 1784–1785): 1780-1784
        • Downar E.
        • Harris L.
        • Kimber S.
        • Mickleborough L.
        • Williams W.
        • Sevaptsidis E.
        • Masse S.
        • Chen T.C.
        • Chan A.
        • Genga A.
        Ventricular tachycardia after surgical repair of tetralogy of Fallot: results of intraoperative mapping studies.
        J Am Coll Cardiol. 1992; 20: 648
        • Nitta T.
        • Kurita J.
        • Murata H.
        • Ohmori H.
        • Sakamoto S.
        • Ochi M.
        • Shimizu K.
        Intraoperative electroanatomic mapping.
        Ann Thorac Surg. 2012; 93: 1285-1288
        • Collins K.K.
        • Rhee E.K.
        • Delucca J.M.
        • Alexander M.E.
        • Bevilacqua L.M.
        • Berul C.I.
        • Walsh E.P.
        • Mayer J.E.
        • Jonas R.A.
        • del Nido P.J.
        • Triedman J.K.
        Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial.
        J Thorac Cardiovasc Surg. 2004; 127: 721-729
        • Theodoro D.A.
        • Danielson G.K.
        • Porter C.J.
        • Warnes C.A.
        Right-sided Maze procedure for right atrial arrhythmias in congenital heart disease.
        Ann Thorac Surg. 1998; 65 (discussion 153–154): 149-153
        • Dearani J.A.
        • Mavroudis C.
        • Quintessenza J.
        • Deal B.J.
        • Backer C.L.
        • Fitzgerald P.
        • Connolly H.M.
        • Jacobs J.P.
        Surgical advances in the treatment of adults with congenital heart disease.
        Curr Opin Pediatr. 2009; 21: 565-572
        • Stulak J.M.
        • Suri R.M.
        • Dearani J.A.
        • Sundt III, T.M.
        • Schaff H.V.
        When should prophylactic Maze procedure be considered in patients undergoing mitral valve surgery?.
        Ann Thorac Surg. 2010; 89: 1395-1401
        • Healey J.S.
        • Crystal E.
        • Lamy A.
        • et al.
        Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.
        Am Heart J. 2005; 150: 288-293
        • Aryana A.
        • D’Avila A.
        • Ruskin J.N.
        • Reddy V.Y.
        The proarrhythmic effect of incomplete pulmotricuspid isthmus ablation in a patient with sarcoid-related ventricular tachycardia?.
        J Cardiovasc Electrophysiol. 2008; 19: 869-872